Table 3 Summary of the results of the meta-analysis of risk factors for sarcopenia in T2DM patients
Risk Factor | Number of Studies (k) | Heterogeneity I2 (%) | Effect Model | Pooled OR [95% CI] | P value |
|---|---|---|---|---|---|
BMI | 12 | 81.4 | Random | 0.63 [0.53–0.75] |  < 0.0001 ** |
Age (Continuous) | 19 | 76.7 | Random | 1.13 [1.11–1.16] |  < 0.0001 ** |
Gender (Male) | 2 | 0.0 | Fixed | 2.37 [1.33–4.21] | 0.0033 * |
Duration of Diabetes | 5 | 86.6 | Random | 1.35 [1.05–2.13] | 0.02 * |
HbA1c | 3 | 75.3 | Random | 1.31 [1.01–2.17] | 0.039 * |
Hypertension | 2 | 63.3 | Random | 3.65 [1.06–12.65] | 0.0409 * |
Physical Activity(No) | 6 | 27.6 | Fixed | 2.54 [1.92–3.36] |  < 0.0001 ** |
Vitamin-D levels | 2 | 0.00 | Fixed | 0.91 [0.87–0.95] |  < 0.001 * |